Logo 20and 20tagline 20preview
Logo 20and 20tagline high 20resolution

SFA Therapeutics, Inc

A Major Advancement in Treating Chronic Inflammatory Diseases

  • Stage Product In Development
  • Industry Biotechnology
  • Location Jenkintown, PA, US
  • Currency USD
  • Founded December 2016
  • Employees 4
  • Incorporation Type C-corp
  • Website sfatherapeutics.com

Company Summary

SFA Therapeutics is developing a 5 anti-inflammatory drugs, based on a microbiome-derived platform. Our first indication in psoriasis has FDA approval to enter phase 2; the second in liver disease is patented (Hepatitis B, NASH, & HCC). Our goal is to demonstrate proof-of-concept, then license these products to strategic partners. Eight patents filed; one issued, one allowed, one accelerated.


  • Bc830ec9 65ce 4ad0 b47f c4a299ae6c18
    Founder and CEO

    Experienced drug developer, with over 25 years of R&D experience, involvement in 33 approved NDAs and 12 medical devices.

  • World-class hepatitis expert

  • GI microbiome expert


Previous Investors

  • Default avatar
    Ben Franklin Technology Partners
    Default avatar
    Axella Bioventures